Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY – Get Rating) shares shot up 1.5% on Thursday . The company traded as high as $35.24 and last traded at $35.18. 23,883 shares traded hands during trading, a decline of 75% from the average session volume of 94,868 shares. The stock had previously closed at $34.66.
Daiichi Sankyo Stock Up 1.5 %
The company’s 50 day simple moving average is $33.09 and its 200 day simple moving average is $31.95.
About Daiichi Sankyo
Daiichi Sankyo Co, Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.
Featured Articles
- Get a free copy of the StockNews.com research report on Daiichi Sankyo (DSNKY)
- Hypercharge Networks: Up Triple Digits, But What’s The Big Deal?
- 3 Reasons Why Apple’s 30% Rally Has Legs
- 3 Reasons to Pick First Citizens Instead of First Republic Bank
- 3 April Earnings Plays for Bullish Swing Traders
- Is Constellation Brands Star About To Rise?
Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.
